Breaking News
July 21, 2018 - Researchers identify subtypes of retinal ganglion cells using single-cell RNA sequencing
July 21, 2018 - Study uncovers opportunities to reduce death by suicide among cancer patients
July 21, 2018 - Genetic sequencing reveals new clues to aggressiveness of prostate cancer
July 21, 2018 - BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
July 21, 2018 - First major study comparing robotic to open surgery published in The Lancet
July 21, 2018 - ADHD medications may fail to improve cognition in healthy college students, study shows
July 21, 2018 - Intervention program that includes a personalized app could benefit teens with suicidal thoughts
July 21, 2018 - Researchers identify new compound that protects against neurodegeneration
July 21, 2018 - Gene therapy may hold potential to treat people with spinal cord injuries
July 21, 2018 - FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
July 21, 2018 - Surgeons have substantial impact on genetic testing in breast cancer patients who need it
July 21, 2018 - Species diversity can have positive and negative impacts on disease transmission
July 21, 2018 - Genome research suggests presence of enteric fever in medieval Europe
July 21, 2018 - Risk of Sensory Deficits Drops With Rising Gestational Age
July 21, 2018 - Mum’s sleep matters—the effect of sleep on an unborn baby
July 21, 2018 - UC San Diego researchers awarded two grants for investigating stem cell-based therapies
July 21, 2018 - Cellular ‘garbage disposal’ may actually work on some of the proteins to neuronal development
July 21, 2018 - More Pregnant Women Having Heart Attacks
July 21, 2018 - Acne Breakouts | NIH News in Health
July 21, 2018 - Change health messaging to focus on potential impact to help stop the next pandemic
July 21, 2018 - Frailty associated with poor survival rates in young heart patients
July 21, 2018 - New discovery could save millions of lives from fatal fungal infections
July 21, 2018 - OBD presents latest data on the use of EpiSwitch™ in predicting patient response to immunotherapy and identifying lymphoma subtypes
July 21, 2018 - Childhood adversity increases susceptibility to addiction via immune response
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
July 21, 2018 - Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints
July 21, 2018 - Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice
July 21, 2018 - SP PennTech introduces RW-500 rotary vial washer for biotech, pharmaceutical applications
July 21, 2018 - Researchers to study molecular mechanisms behind susceptibility of males to autism
July 21, 2018 - Researchers study efficacy and safety of new treatment for OUD
July 21, 2018 - Fourth Published Clinical Trial Confirms Long-Term Safety of Niagen Supplementation at High Doses and Shows Potential for Improvement in Liver Health
July 21, 2018 - Study examines effects of a two-day intermittent calorie restriction diet for patients with type 2 diabetes
July 21, 2018 - Greening vacant urban land reduces feelings of depression for surrounding residents
July 21, 2018 - Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older
July 21, 2018 - Collaborative study to assess effects of exercise training for cognitive deficits in MS
July 21, 2018 - FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system
July 21, 2018 - Protective qualities of ‘good cholesterol’ reduce after menopause
July 21, 2018 - Researchers develop new way to uncover hidden breast cancer tumors
July 21, 2018 - FDA approves first drug for treatment of adult AML patients with specific genetic mutation
July 21, 2018 - Top AI companies join hands to discover novel drugs for DMD
July 21, 2018 - Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications
July 20, 2018 - Researchers design proteins that can self-assemble into complex structures
July 20, 2018 - AVITA Medical expands management team to support launch of RECELL device to treat burns
July 20, 2018 - FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
July 20, 2018 - Developmental screening and surveillance rates remain low, new study suggests
July 20, 2018 - TGen opens tissue donation portal to advance DIPG research
July 20, 2018 - Health impact of highly processed summertime staples
July 20, 2018 - Exergaming can improve health in overweight and obese children, study shows
July 20, 2018 - Postmenopausal factors may impact heart-protective qualities of ‘good cholesterol’
July 20, 2018 - MRI and blood test combination results in improved prostate cancer diagnosis
July 20, 2018 - Update Health Professional and Consumer on Recent Recalled Products
July 20, 2018 - Researchers trace Parkinson’s damage in the heart
July 20, 2018 - Wearable device designed to measure cortisol in sweat
July 20, 2018 - Scientists demonstrate a new regulation mechanism for skeletal muscles
July 20, 2018 - Exposure to mobile phone radiation may negatively impact memory performance in adolescents
July 20, 2018 - SUSU scientists find alternative method to treat post-traumatic stress disorder syndrome
July 20, 2018 - Gestational diabetes may increase offspring’s heart disease risk
July 20, 2018 - New vaccine could protect unborn babies from Zika virus
July 20, 2018 - Researchers find high mercury and methylmercury concentrations in traditional Tibetan medicine
July 20, 2018 - Brief Safety Plan Intervention in ER Can Cut Suicidal Behavior
July 20, 2018 - The Mount Sinai Hospital receives accreditation as geriatric emergency department
July 20, 2018 - Toward a better understanding of Parkinson’s disease
July 20, 2018 - Med school communications office wins four national awards | News Center
July 20, 2018 - Professional baseball players with faster hand-eye coordination may have better batting performance
July 20, 2018 - Study looks into mechanisms that control sleep and wakefulness
July 20, 2018 - Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments
July 20, 2018 - Research reveals long-term efficacy of drug used to treat common cause of kidney failure
July 20, 2018 - Timing of dinner associated with breast and prostate cancer risks
July 20, 2018 - Health Tip: Performing the Heimlich Maneuver
July 20, 2018 - Nearly all adolescents have eating, activity or weight-related issues
July 20, 2018 - Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s
July 20, 2018 - High-performance porous polymeric material for chromatography applications
July 20, 2018 - New molecule shows great promise for future treatment of many cancers
July 20, 2018 - New research project investigates alternative treatments for eye infections
July 20, 2018 - Immune T cells are built to react as fast as possible, shows study
July 20, 2018 - ZHX2 protein could offer a new treatment strategy for kidney cancer
July 20, 2018 - EKF’s Quo-Lab POC HbA1c analyzer meets international quality targets for diabetes testing
July 20, 2018 - Health burdens of very high risk drinking are potentially large, study reveals
New learn about goals to check protection and efficacy of antiplatelet drug in fighting blood clots

New learn about goals to check protection and efficacy of antiplatelet drug in fighting blood clots

image_pdfDownload PDFimage_print

A brand new medical learn about is beginning on the German Centre for Cardiovascular Analysis (DZHK) with an leading edge and extremely explicit blood thinner. Headed through the DZHK Munich website, the scientists need to verify how safely and successfully this compound, which handiest acts in the community, can save you blood clots in sufferers with a coronary center illness being handled with a cardiac catheter.

The coronary vessels are blocked in coronary center illness. If physicians dilate the vessels with a catheter, the deposits (plaques) can tear and injury the partitions of the blood vessels. Such small damages are a chance issue for circulatory issues and center assaults, as platelets can adhere to those websites and clots can shape. Sufferers due to this fact obtain blood thinning medication that save you platelet accumulation all over the process. The downside of the medication used up to now is that in addition they build up the chance of probably existence‑threatening bleedings, as a result of they inhibit a central step of haemostasis, or platelet accumulation, in all the frame. The aim of the DZHK learn about, which is headed through the German Center Centre Munich, is to analyze whether or not the brand new antiplatelet drug Revacept reduces the formation of blood clots all over cardiac catheterization with out expanding the bleeding chance. Compared to standard blood thinners, Revacept handiest binds to the broken websites within the vessel and shields them in order that no platelets can gather there. “Revacept is sort of a plaster that seals the lesion in a centered method”, exemplifies PD Dr. Stefanie Schüpke of the German Center Centre Munich.

From the laboratory to the affected person

Years of extensive fundamental analysis, by which scientists at LMU Munich and the Technical College Munich researched how platelets adhere to broken vessel websites, preceded the advance of Revacept. “It was once an important to focus on constructions that distinguish between wholesome and atherosclerotic vessels”, explains Prof. Adnan Kastrati of the German Center Centre Munich, probably the most leader investigators. Because of this, the scientists targeted at the adhesion of platelets to the collagen that handiest protrudes into the blood circulation the place vessel partitions are broken. The agent Revacept was once created in keeping with their findings. It binds to the collagen of the broken websites in a centered method and thus prevents the adhesion of platelets. “Revacept is an instance of a hit translational analysis, by which the findings from fundamental analysis result in the advance of leading edge remedies”, clarifies Prof. Thomas Eschenhagen, the consultant of the DZHK Board of Administrators.

For the primary time in sufferers with coronary center illness

Revacept was once additional evolved right into a drug to be used in people through the biotech corporate advanceCOR, a spin-off of the Technical College Munich. A prior learn about with wholesome volunteers has already confirmed that Revacept is secure and smartly tolerated. Additionally, a medical trial is already being performed investigating Revacept in stroke sufferers. Within the upcoming learn about, 332 sufferers with a coronary center illness for whom a catheterization is deliberate can be tested. Some sufferers can be handled with Revacept along with the standard drugs. Right through the learn about, bleeding chance can be monitored and a marker within the blood can be used to analyze whether or not Revacept sufficiently prevents injury of the guts muscle. In general, six DZHK websites are taking part within the learn about, which is co-financed through the producer, advanceCOR GmbH in Martinsried.


Posted in: Drug Trial Information | Clinical Process Information | Clinical Situation Information

Tags: Blood, Blood Vessels, Catheter, Scientific Trial, Collagen, Compound, Coronary Center Illness, Medication, Center, Center Illness, Laboratory, Muscle, Platelets, Stroke

Tagged with:

About author

Related Articles